Anti-HIV Agent MAP30 Modulates the Expression Profile of Viral and Cellular Genes for Proliferation and Apoptosis in AIDS-Related Lymphoma Cells Infected with Kaposi's Sarcoma-Associated Virus
- 5 October 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 287 (4) , 983-994
- https://doi.org/10.1006/bbrc.2001.5689
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Nuclear Factor-κB-inducible Death Effector Domain-containing Protein Suppresses Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Caspase-8 ActivityJournal of Biological Chemistry, 2001
- The Protective Role of HSP90 against 3-Hydroxykynurenine-Induced Neuronal ApoptosisBiochemical and Biophysical Research Communications, 2001
- Molecular virology of Kaposi's sarcoma–associated herpesvirusPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicityOncogene, 2000
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- Interleukin 2 and its receptors: recent advances and new immunological functionsImmunology Today, 1996
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- MAP 30: a new inhibitor of HIV‐1 infection and replicationFEBS Letters, 1990